Anti-TNF and systemic corticosteroid exposure were also associated with an increased risk of COVID-19-associated hospitalisation (HR: 1.8, 95% CI 1.0 to 3.3 and HR: 1.8, 95% CI 1.0 to 3.0, respectively; figure 4). This evidence concerns the gene TNF and COVID-19.